Purpose of the development: The developed method is proposed for use as a highly efficient and secure means of correction, pharma endotoxicosis in crush syndrome using synthesized oxy Leaded dandy phospho natogermanatu magnesium.

Recommended application field: Development can be realized by the enterprises and organizations of the Ministry of Industrial Policy of Ukraine and the Ministry of Health of Ukraine.

Advantages over analogues: The invention is related to new chemical compounds, process for its preparation and the pharmacological action, has no analogues. Oxy Leaded dandy phospho natogermanat magnesium exhibits significantly greater detoxifying effect than the reference drug - thiotriazoline (JSC "Galichparm", Ukraine).

The development stage readiness: tested in laboratory condition

Technical and economic effect: Thanks to the environmentally sound synthesis in aqueous solutions, low energy costs, availability of raw materials in Ukraine for making connections, as well as its high detoxication effect and low toxicity, production developed preparation seems profitable. Estimated cost can be calculated after detailed testing and serial production.

Description of the development:
()
Developers have created a new pharmacological drug - geterometalny complex germanium and magnesium oxiethilidendiphosphone acid, which due to its structure, properties and low toxicity exhibits a high protective effect in conditions of endotoxemia traumatic genesis and can be used in clinical medicine. Implementation requires further clinical trials.

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Reguires revision

Possibility of transfer abroad:
Licence's sale
Licence's sale
Combinated reduction to industrial level

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua